Weight loss drug is not taking easy way out

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.